• Register
  • Login

European Journal of Molecular & Clinical Medicine

  • Home
  • Browse
    • Current Issue
    • By Issue
    • By Subject
    • Keyword Index
    • Author Index
    • Indexing Databases XML
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Indexing and Abstracting
    • Peer Review Process
    • News
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
Advanced Search

Notice

As part of Open Journals’ initiatives, we create website for scholarly open access journals. If you are responsible for this journal and would like to know more about how to use the editorial system, please visit our website at https://ejournalplus.com or
send us an email to info@ejournalplus.com

We will contact you soon

  1. Home
  2. Volume 2, Issue 2
  3. Author

Online ISSN: 2515-8260

Volume2, Issue2

Modeling and simulation the conduit connecting translational medicine with portfolio management

    Parviz Ghahramani

European Journal of Molecular & Clinical Medicine, 2015, Volume 2, Issue 2, Pages 63-64

  • Show Article
  • Download
  • Cite
  • Statistics
  • Share

Abstract

Translational medicine science and the volume of information generated in this field have grown exponentially in the last decade and continue to grow faster every day. This has generated a huge amount of data. The application of Modeling and Simulation (M&S) in drug development has also grown in the last two decades, but mostly has been limited to analysis of single studies or to analysis of pooled data from several studies. Such application traditionally has been used either to support a new drug application or to make Go/No Go decisions about a given development program. However, rarely M&S has been integrated as a tool in portfolio management based on a quantitative evaluation of all the data in hand (e.g., translational Medicine data). In other words, many organizations utilize M&S still as a tool aiding study data analysis or at best a tool to guide a given development program, but not use M&S in portfolio management systematically (the large dashed box shown in the Fig. 1).
Keywords:
    . Therefore
  • PDF (111 K)
  • XML
(2015). Modeling and simulation the conduit connecting translational medicine with portfolio management. European Journal of Molecular & Clinical Medicine, 2(2), 63-64.
Parviz Ghahramani. "Modeling and simulation the conduit connecting translational medicine with portfolio management". European Journal of Molecular & Clinical Medicine, 2, 2, 2015, 63-64.
(2015). 'Modeling and simulation the conduit connecting translational medicine with portfolio management', European Journal of Molecular & Clinical Medicine, 2(2), pp. 63-64.
Modeling and simulation the conduit connecting translational medicine with portfolio management. European Journal of Molecular & Clinical Medicine, 2015; 2(2): 63-64.
  • RIS
  • EndNote
  • BibTeX
  • APA
  • MLA
  • Harvard
  • Vancouver
  • Article View: 39
  • PDF Download: 73
  • LinkedIn
  • Twitter
  • Facebook
  • Google
  • Telegram
Journal Information

Publisher:

Email:  info@ejmcm.com

  • Home
  • Glossary
  • News
  • Aims and Scope
  • Privacy Policy
  • Sitemap

Editorial Team:  editor@ejmcm.com

For Special Issue Proposal : chiefeditor.ejmcm@gmail.com / info@ejmcm.com

This journal is licensed under a Creative Commons Attribution 4.0 International (CC-BY 4.0)

Powered by eJournalPlus